These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors. Garfield EM, Walton KE, Quan VL, VandenBoom T, Zhang B, Kong BY, Isales MC, Panah E, Kim G, Gerami P. J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057 [Abstract] [Full Text] [Related]
4. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma. Watchorn RE, Calonje E, Taibjee SM. Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497 [Abstract] [Full Text] [Related]
5. Novel insights into the BAP1-inactivated melanocytic tumor. Donati M, Martinek P, Steiner P, Grossmann P, Vanecek T, Kastnerova L, Kolm I, Baneckova M, Donati P, Kletskaya I, Kalmykova A, Feit J, Blasch P, Szilagyi D, Baldi A, Persichetti P, Crescenzi A, Michal M, Kazakov DV. Mod Pathol; 2022 May; 35(5):664-675. PubMed ID: 34857909 [Abstract] [Full Text] [Related]
6. RAF1 Gene Fusions as a Possible Driver Mechanism in Rare BAP1-Inactivated Melanocytic Tumors: A Report of 2 Cases. Donati M, Martinek P, Kastnerova L, Persichetti P, Michal M, Kazakov DV. Am J Dermatopathol; 2020 Dec; 42(12):961-966. PubMed ID: 32769548 [Abstract] [Full Text] [Related]
15. Ambiguous melanocytic tumors with loss of 3p21. Yeh I, Mully TW, Wiesner T, Vemula SS, Mirza SA, Sparatta AJ, McCalmont TH, Bastian BC, LeBoit PE. Am J Surg Pathol; 2014 Aug; 38(8):1088-95. PubMed ID: 24705312 [Abstract] [Full Text] [Related]
16. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome. Silva-Clavería F, Álvarez-Muñoz A, Ferrándiz L, Fernández-Orland A, Conde-Martin AF, Moreno-Ramírez D, Ríos-Martín JJ. Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128 [Abstract] [Full Text] [Related]
17. A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor. Linos K, Atkinson AE, Yan S, Tsongalis GJ, Lefferts JA. J Cutan Pathol; 2020 May; 47(5):485-489. PubMed ID: 31891422 [Abstract] [Full Text] [Related]
18. BAP1-inactivated melanocytic tumour with borderline histopathological features (BAP1-inactivated melanocytoma): A case report and a reappraisal. Ferrara G, Mariani MP, Auriemma M. Australas J Dermatol; 2021 Feb; 62(1):e88-e91. PubMed ID: 33107024 [Abstract] [Full Text] [Related]